IL51043A - Pharmaceutical compositions comprising ergot-type compounds and heparin - Google Patents

Pharmaceutical compositions comprising ergot-type compounds and heparin

Info

Publication number
IL51043A
IL51043A IL51043A IL5104376A IL51043A IL 51043 A IL51043 A IL 51043A IL 51043 A IL51043 A IL 51043A IL 5104376 A IL5104376 A IL 5104376A IL 51043 A IL51043 A IL 51043A
Authority
IL
Israel
Prior art keywords
ergot
heparin
pharmaceutical compositions
type compounds
compounds
Prior art date
Application number
IL51043A
Other versions
IL51043A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2554533A external-priority patent/DE2554533C3/en
Priority claimed from DE19762625403 external-priority patent/DE2625403A1/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL51043A0 publication Critical patent/IL51043A0/en
Publication of IL51043A publication Critical patent/IL51043A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Electronic Switches (AREA)
IL51043A 1975-12-04 1976-12-02 Pharmaceutical compositions comprising ergot-type compounds and heparin IL51043A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2554533A DE2554533C3 (en) 1975-12-04 1975-12-04 Use of dihydroergotamine and heparin
DE19762625403 DE2625403A1 (en) 1976-06-05 1976-06-05 Antithrombotic association of medicaments - contains heparin and an ergoline-(8)-carboxylic acid peptidic amide esp. dihydroergotamine opt. with polyvinyl pyrrolidone

Publications (2)

Publication Number Publication Date
IL51043A0 IL51043A0 (en) 1977-02-28
IL51043A true IL51043A (en) 1980-02-29

Family

ID=25769698

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51043A IL51043A (en) 1975-12-04 1976-12-02 Pharmaceutical compositions comprising ergot-type compounds and heparin

Country Status (17)

Country Link
JP (1) JPS5270031A (en)
AU (1) AU512782B2 (en)
CS (1) CS216164B2 (en)
ES (1) ES453869A1 (en)
FR (1) FR2333513A1 (en)
GB (1) GB1557331A (en)
HK (1) HK3083A (en)
IE (1) IE44359B1 (en)
IL (1) IL51043A (en)
IT (1) IT7827782A0 (en)
MY (1) MY8400064A (en)
NL (1) NL172401C (en)
NZ (1) NZ182790A (en)
PH (1) PH12759A (en)
PT (1) PT65919B (en)
SE (1) SE441142B (en)
SG (1) SG63482G (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809618A1 (en) * 1978-03-06 1979-09-20 Sandoz Ag NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
CH656533A5 (en) * 1982-12-10 1986-07-15 Sandoz Ag THERAPEUTIC PREPARATION CONTAINING HYDRATED ERGOTAL CALOIDS AND LOW MOLECULAR HEPARINE.

Also Published As

Publication number Publication date
NL172401C (en) 1983-09-01
CS216164B2 (en) 1982-10-29
IE44359L (en) 1977-06-04
HK3083A (en) 1983-01-20
GB1557331A (en) 1979-12-05
ES453869A1 (en) 1978-01-16
NL172401B (en) 1983-04-05
MY8400064A (en) 1984-12-31
NL7613316A (en) 1977-06-07
JPS5270031A (en) 1977-06-10
AU2024976A (en) 1978-06-08
AU512782B2 (en) 1980-10-30
PT65919A (en) 1977-01-01
SE7613252L (en) 1977-06-05
FR2333513B1 (en) 1980-03-28
NZ182790A (en) 1979-03-16
PT65919B (en) 1978-07-05
SE441142B (en) 1985-09-16
SG63482G (en) 1983-09-09
FR2333513A1 (en) 1977-07-01
IT7827782A0 (en) 1978-09-18
IE44359B1 (en) 1981-11-04
PH12759A (en) 1979-08-09
IL51043A0 (en) 1977-02-28

Similar Documents

Publication Publication Date Title
ZA7671B (en) Pharmaceutical composition
JPS5272829A (en) Pharmaceutical composition
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
IL51087A0 (en) New polyhalogeno-steroids their manufacture and pharmaceutical compositions containing them
ZA763917B (en) Pharmaceutical compositions and compounds
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
HK42382A (en) Pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
NZ181401A (en) 2-benzopyranone derivatives and pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
NZ181146A (en) Benzocycloheptathiophene derivatives and pharmaceutical compositions
ZA767215B (en) Pharmaceutical compositions
IE42772L (en) Pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
ZA761880B (en) New pharmaceutical compositions
IL51043A (en) Pharmaceutical compositions comprising ergot-type compounds and heparin
NZ183436A (en) Substituted phenylguanidines and pharmaceutical compositions
PH11642A (en) Benzocycloheptothiophenes and pharmaceutical compositions
IL50854A (en) D-homosteroids their manufacture and pharmaceutical compositions containing them